title: Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment.
authors.affiliation: Department of Internal Medicine, Meir Medical Center, Kfar Saba, Israel.
authors.forename: Noa
authors.initials: N
authors.lastname: Klein
authors.forename: Avishay
authors.initials: A
authors.lastname: Elis
authors.forename: Judith
authors.initials: J
authors.lastname: Radnay
authors.forename: Ruth
authors.initials: R
authors.lastname: Zemer
authors.forename: Ami
authors.initials: A
authors.lastname: Klein
authors.forename: Michael
authors.initials: M
authors.lastname: Lishner
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002471:Cell Transformation, Neoplastic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D054219:Neoplasms, Plasma Cell / Q000473:pathology*; D016066:Pleural Effusion, Malignant / Q000473:pathology*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab